tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate

LCZ696 是美国 Novartis Pharmaceuticals 开发的一种心力衰竭治疗药物。心力衰竭是一种危及生命、使人衰弱的疾病，其中心脏无法泵出足够的血液来供应身体。呼吸急促、疲劳和体液潴留等症状可能会逐渐发展并随着时间的推移而恶化，从而严重影响生活质量。

Monomethyl auristatin E, abbreviated as MMAE, is a synthetic antitumor agent. Due to its toxicity, it cannot be used as a drug alone but is instead conjugated to monoclonal antibodies (mAb). It is an effective antimitotic agent derived from dolastatin, a peptide found in the marine mollusk Dolabella auricu...

AP>99%

Palbociclib (monohydrochloride) is a highly selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), which play a crucial role in regulating cell cycle progression. By inhibiting CDK4/6, Palbociclib effectively arrests cell cycle progression, particularly in cancer cells that rely on CDK4/6 activi...

特格拉赞  AP≥99.0%  USDMF：43136

AP>99% 100g; 1kg; 10kg

Purity：99% 100g;1kg;10kg

VcMMAE (mc-vc-PAB-MMAE) is a biochemical reagent and a part of antibody-drug conjugates (ADCs) as a drug-linker conjugate. It exhibits anticancer activity and is composed of MMAE (a tubulin inhibitor) connected via a Vc linker.

API of Vonoprazan fumarate for the treatment of Reflux esophagitis

(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid is an organic compound containing a tert-butoxycarbonyl (Boc) protecting group, primarily used as a pharmaceutical intermediate. This compound introduces a tert-butoxycarbonyl group to the amino group to protect it, ens...

The melting point of 2-chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one is between 176°C and 178°C, with a density of 1.3. Under normal temperature and pressure, it appears as a yellow or dark yellow solid. Its solubility in chloroform and methanol is moderate, but it dissolves better when hea...

2'-Deoxy-2'-fluorocytidine can synergize with T705 to enhance the antiviral efficacy of both compounds against CCHFV replication, and is widely used in the development of antiviral bioactive molecules and drug molecules. Firstly, it has garnered significant attention as an effective inhibitor of Crimean-Co...

ChemExpress Proudly Joins the ACS GCIPR to Advance Green Chemistry! 

Founded in 2006, ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization.

ChemExpress have been shortlisted for Best CRO (Contract Research Organization) at the 11th World ADC Awards. 

ChemExpress CDMO Services brochure (CDMO）

ChemExpress have received EIR with the conclusion of the inspection, no FDA 483, Observations, was issued by US FDA on August 8th.

ChemExpress ADC Products handbook (ADC)

ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. 

ChemExpress FTE & FFS Services Flyer (FTE&FFS)

DMF Filed ADC Small Molecule Products